SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is drawing heavy community discussion as investors debate whether Nvidia's massive memory supply commitments and surging demand will finally trigger a sustained breakout or spark profit-taking.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the completion of its first German packaging and labeling run for Anktiva, fueling optimism around European expansion and international revenue growth. The community is actively discussing potential short squeeze dynamics, upcoming catalysts, and the broader outlook for the company's immunotherapy platform.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares rallied following a strong earnings beat and robust revenue guidance, while the community actively debated valuation concerns, short squeezes, and memory supply constraints.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is rallying alongside a broader crypto market recovery and Bitcoin's push above key resistance levels. Traders are actively debating the impact of recent equity dilution, potential short squeeze dynamics, and whether the stock can sustain its momentum toward higher price targets.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce shares surged following a strong quarterly report and the announcement of an expanded partnership with Anthropic, helping dispel broader market concerns about AI disruption in software.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trading on high retail volume as the community anticipates the imminent Phase 3 REGAL trial data readout, while drawing broader sector comparisons to recent oncology drug approvals and Cathie Wood's backing of personalized cancer vaccines.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike shares surged following a strong quarterly earnings report and a raised full-year outlook, driven by accelerating enterprise demand for AI security tools and record annual recurring revenue. The community is buzzing over the single-day rally and widespread Wall Street price target hikes, though some retail traders remain cautious about the stock's high valuation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is surging past double digits as strong institutional buying, significant short interest, and optimism surrounding the upcoming regulatory review fuel heavy momentum.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta shares surged following strong quarterly results and raised guidance, with investors and retail communities actively discussing how the AI agent boom is driving increased demand for identity and security management.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is trading in the spotlight as investors debate the impact of the company's operational reset, delayed midsize vehicle timeline, and strategic pivot toward robotaxi partnerships with Uber.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XBOTF well I asked ChatGPT what is the price prediction per merger closing? It said strongly $8… ￼ we shall see 🔥🔥🔥

AJ M (Vash)

Phoebe Burwell

Dad Suggests Stocks

LoganFive

Kevin Jr

Thomas

Adam Mac

StockTwits for iOS

Realbotix Corp.

 well I asked ChatGPT what is the price prediction per merger closing? It said strongly $8… ￼ we shall see 🔥🔥🔥

@stoiclove LMFAO ChatGPT also claimed that Freddie Freeman was Jewish.  Trust me, it has no idea what XBOTF is.

StockTwits Web

 LMFAO ChatGPT also claimed that Freddie Freeman was Jewish.  Trust me, it has no idea what XBOTF is.

Matt Unger

@stoiclove Btw this is what ChatGPT is saying about XBOTF merger.. Nice lie on the $8 though 
 
My post-merger price scenarios 
Scenario Approx. price What would have to happen 
🔴 Bear $0.10–$0.20 Dilution + weak execution / Nasdaq listing fails to attract investors 
🟡 Conservative $0.30–$0.50 Successful merger and Nasdaq listing, but limited revenue growth 
🟢 Bull $0.75–$1.50 Listing creates substantial visibility + commercial robot contracts

 Btw this is what ChatGPT is saying about XBOTF merger.. Nice lie on the $8 though 
 
My post-merger price scenarios 
Scenario Approx. price What would have to happen 
🔴 Bear $0.10–$0.20 Dilution + weak execution / Nasdaq listing fails to attract investors 
🟡 Conservative $0.30–$0.50 Successful merger and Nasdaq listing, but limited revenue growth 
🟢 Bull $0.75–$1.50 Listing creates substantial visibility + commercial robot contracts

@Bulls1983 actually dumbass I factored in more information revolving around the fourth industrial revolution so if you have any knowledge on what I’m talking about then I think we will be in agreement

 actually dumbass I factored in more information revolving around the fourth industrial revolution so if you have any knowledge on what I’m talking about then I think we will be in agreement